|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/57 | (2006.01) |
| A61K 38/57 | (2013.01) | ||
| A61P 37/06 | (2006.01) | ||
| A61P 37/06 | (2018.01) |
| (11) | Number of the document | 3716998 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18821851.5 |
| Date of filing the European patent application | 2018-11-30 | |
| (97) | Date of publication of the European application | 2020-10-07 |
| (45) | Date of publication and mention of the grant of the patent | 2024-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/063179 |
| Date | 2018-11-30 |
| (87) | Number | WO 2019/108865 |
| Date | 2019-06-06 |
| (30) | Number | Date | Country code |
| 201762593446 P | 2017-12-01 | US | |
| 201862729376 P | 2018-09-10 | US |
| (72) |
UKNIS, Marc , US
VOIGT, Christine , US
BAHETI, Gautam , US
ROBERTS, John , US
|
| (73) |
CSL Behring LLC ,
1020 First Avenue, King of Prussia, PA 19406,
US
|
| (54) | A1AT FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION |
| A1AT FOR REDUCING RISK OF ONSET OF ACUTE GRAFT VERSUS HOST DISEASE AFTER HEMATOPOEITIC CELL TRANSPLANTATION |